“The people’s cancer cure”
Groundbreaking research could lead to
a safe, affordable cure
Imagine a world in which there’s a cure for cancer, it’s widely available, and it’s dirt cheap. The cure isn’t owned by Big Pharma or any other money-hungry organization looking to cash in on other people’s misfortunes. Instead, it’s owned by “we, the people.”
Sounds too good to be true, right?
Let me tell you about DCA——and then you can decide for yourself if it’s too good to be true.
What if everything you think you know about cancer is wrong?
About four years ago, a cardiologist challenged what we thought we knew about cancer. He went out on a limb, bucked the system, and ultimately uncovered what could be the greatest cancer-defeating discovery in history.
This discovery isn’t a synthetic compound mixed together in Big Pharma’s potion-mixing labs, and it’s not a complicated, risky procedure that has as many risks as it does rewards. This is the discovery of a common, non-toxic, and inexpensive chemical that has the ability to kill almost any and every cancer.
It’s called DCA (which is short for dichloroacetate). DCA has been widely used up in Canada for years to treat children with inborn errors of metabolism due to mitochondrial diseases. That’s what tipped off Evangelos Michelakis of the University of Alberta in Edmonton, Canada, to DCA’s potential role in treating cancer.
You see, it’s long been believed that cancer cells kill off healthy cell’s mitochondria——that’s the part of the cell that’s responsible for causing a cell to self-destruct when it’s damaged beyond repair. Cancer’s power to turn off a cell’s ability to die is what makes the disease so difficult to treat. Because in doing so, cancer essentially makes itself immortal .
But every Immortal has a fatal flaw, and cancer is no different.
Finally, someone found cancer’s kryptonite
It’s a brilliant idea. I don’t know why someone didn’t think of it sooner. Rather than actually attacking the cancer cells (and your healthy cells in the process), DCA causes the cancer to self-destruct from the inside out. How? It takes away cancer’s immortality by restoring the mitochondria.
“I think DCA can be selective for cancer because it attacks a fundamental process in cancer development that is unique to cancer cells,” Michelakis said. “ One of the really exciting things about this compound is that it might be able to treat many different forms of cancer.”
When Michelakis first tested DCA in rats that were deliberately infected with human cancer, their tumors shrank drastically. Then, on human cells cultured outside the body, he found that it killed lung, breast, and brain cancer cells.
These initial studies were so cutting edge——and so revolutionary——that Newsweek said...
“If there were a magic bullet, it might be something like DCA.”
And magic bullet it is. I’ve told you many times about the blood-brain barrier. This barrier surrounds and protects your brain internally in the same way your skull protects your brain externally. The BBB is your brain’s Ft. Knox——it’s very selective in what it allows through. This can be a double-edged sword. It’s good if you’re concerned about toxins and other harmful substances. It’s not so good when it keeps out life-saving substances.
But that is exactly why DCA lives up to its “magic bullet” nickname. It has the ability to cross the blood-brain barrier. What that means is that...
This unique substance stands alone in its ability to treat brain cancer
A study on DCA recently published in the journal Science Translational Medicine showed that DCA has the potential to treat one of the most common forms of brain cancer .
It’s called glioblastoma. Without treatment, patients with this type of cancer live about three months. With standard treatment, the current survival rate for glioblastoma patients is about 14 to 16 months.
In this initial clinical trial, Michelakis treated five patients with advanced glioblastoma and found that...
DCA extended the lives of 80 percent of the study participants.
The patients had no further brain cancer growth 15 months after initial treatment, and follow-up studies showed that the DCA caused the cancer cells to die.
However, as positive as these results are, the study was small, and there was no placebo control. Technically, this means that the results are inconclusive until more research can be done. Of course, that hasn’t stopped certain physicians from using DCA off-label for their cancer patients.
Real-world results for this breakthrough treatment
Despite inconclusive results in the initial human study, some doctors in Canada still prescribe DCA off-label to their cancer patients. (This is possible in Canada because DCA is already approved for the treatment of metabolism disorders.) Like cancer doctor Akbar Khan of Medicor Cancer Centre in Toronto, for example. Khan said, “We are seeing about 60 to 70 percent of patients who have failed standard treatments respond favorably to DCA.”
Khan even had a peer-reviewed paper published in the Journal of Palliative Medicine . Khan said, “It’s a case report of a patient with a rare form of cancer who had tried other treatments that weren’t working, so he came to us for DCA. It was effective, and actually it’s quite a dramatic result. He had multiple tumors, including a particularly troubling one in his leg. DCA stabilized the tumor and significantly reduced his pain.”
He continued, “We currently have three patients with incurable cancers who are in complete remission, and are likely cured, from using DCA in combination with conventional palliative (non-curative) treatments. We are in the process of publishing these cases.”
If the initial research is positive, and the real-life experiences are positive, what’s the holdup?
Is Big Pharma standing in the way of the world’s greatest cancer cure?
Yes and no.
The pharmaceutical world isn’t exactly standing in the way of DCA’s success, but it’s not helping either.
Clinical trials are complicated, time-consuming, and expensive. The only way a company would invest that kind of time and money into a substance would be if they stood to ultimately gain from it. That’s why natural substances rarely undergo the kinds of studies done by pharmaceutical companies. Natural substances aren’t patentable, so no one stands to make big gains from studying it.
And of course, if there are no studies, the FDA will never approve it as a treatment for cancer. It’s the worst kind of catch 22 possible .
The world may never benefit from what could possibly be the most promising cancer cure we’ve ever seen ——all because this substance is so cheap, and so widely used that it’s unpatentable.
But that hasn’t stopped Michelakis from moving forward with research for this wonder drug. Through radio shows, websites, community efforts, and more, he raised the $1.5 million necessary to conduct the first small-scale clinical trial. Now that the trial was successful, he needs more money in order to conduct further research.
If you’re waiting for the government to step in and help out, don’t hold your breath. Their research grants wouldn’t put a dent in the kind of money necessary for adequate testing.
But despite lack of funding, and despite any support from companies that have the money to prove once and for all that DCA is the greatest cancer cure we’ve ever seen, Michelakis is pushing forward.
Plenty of people are comparing his efforts with those of medical researcher Jonas Salk, the discoverer of the first successful polio vaccine. When you consider the fact that the polio vaccine gave people immunity to a deadly disease that affected more than 300,000 Americans every year, you’d think someone would have made a boatload of money from discovering the cure.
But when asked who owned the patent on the vaccine, Salk famously replied, “Well, the people, I would say. There is no patent. Could you patent the sun?”
In the same way that “the people” owned the polio vaccine, we also have the opportunity to be a part of developing a cure for cancer that’s not owned by Big Pharma or anyone else.
“We challenged the dogma that without industry you can’t actually test drugs on human beings,” Michelakis said of the $1.5 million raised for the first clinical trial. “This could be a social experiment where the public funds these trials.”
If you would like to be a part of this “social experiment,” you can make your own donation to “the people’s cancer cure” by going to the Official University of Alberta DCA website, www.dca.med.ualberta.ca . Click on “Donations.”
You can also mail donations to:
University of Alberta, Office of Development
3rd Floor Enterprise Square
3-501, 10230 Jasper Avenue NW
Edmonton, Canada T5J 4P6
Note on the memo line that you would like your donations to support Dr. Michelakis’ cancer research.
p.s. One more thing about the brilliant research of Dr. Evangelos Michelakis. His research also takes another approach to how cancer spreads that’s too interesting not to share with you.
Besides initiating cell death (apoptosis), mitochondria serve another critical role: they’re your cells’ primary energy source. Unlike healthy cells, cancer cells don’t use mitochondria as their energy source—they make their energy through the main body of the cell. This process is called glycolysis. The problem is that this is an inefficient form of energy, and it uses vast amounts of sugar to fuel the process.
Michelakis suggests that this transition happens when a benign tumor forms, and the cells in the middle don’t get enough oxygen for their mitochondria to work properly. That causes the mitochondria to switch off, and the cells starts producing energy through glycosis instead.
That explains why the mitochondria are no longer working, and why the cancer cells won’t self-destruct. It also helps to explain how cancer spreads. Glycosis forms lactic acid. Lactic acid can break down the collagen fibers that hold cells together. The “loose” cells can then break off and spread to another part of the body where it can “seed” new tumors.
If this explanation holds true, DCA could not only cause cancer cells to die, but could also prevent the disease from spreading. Now that’s what I call groundbreaking research.
You can be sure I’ll keep you posted on further updates on DCA.